Assembly Biosciences (ASMB) Non-Current Deferred Tax Liability (2014 - 2021)
Assembly Biosciences (ASMB) posted quarterly Non-Current Deferred Tax Liability of $2.5 million for Q3 2021, little changed year-over-year from $2.5 million in Q3 2020, and little changed quarter-over-quarter from $2.5 million in Q2 2021.
Assembly Biosciences (ASMB) Non-Current Deferred Tax Liability (2014 - 2021) Analysis & Trends
Assembly Biosciences' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $2.5 million for Q3 2021.
- In Q3 2021, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $2.5 million; the TTM figure through Sep 2021 stood at $2.5 million (changed 0.0% YoY), while the FY2020 annual figure was $2.5 million, changed 0.0% from the prior year.
- Non-Current Deferred Tax Liability for Q3 2021 stood at $2.5 million, roughly flat from $2.5 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $3.3 million in Q4 2018, with the low at $2.1 million in Q4 2017.
- The 5-year median for Non-Current Deferred Tax Liability is $2.5 million (2019), against an average of $2.7 million.
- The sharpest annual moves came in 2017 and 2018: Non-Current Deferred Tax Liability sank 80.79% in 2017, then jumped 52.25% in 2018.
- Assembly Biosciences' Non-Current Deferred Tax Liability stood at $2.1 million in 2017, then surged by 52.25% to $3.3 million in 2018, then retreated by 22.17% to $2.5 million in 2019, then changed by 0.0% to $2.5 million in 2020, then changed by 0.0% to $2.5 million in 2021.
- Business Quant data shows ASMB's Non-Current Deferred Tax Liability at $2.5 million in Q3 2021, $2.5 million in Q2 2021, and $2.5 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2.53 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Jun 30, 2021 | 2.53 Mn |
| Jun 30, 2021 | 2.53 Mn |
| Mar 31, 2021 | 2.53 Mn |
| Mar 31, 2021 | 2.53 Mn |
| Dec 31, 2020 | 2.53 Mn |
| Dec 31, 2020 | 2.53 Mn |
| Sep 30, 2020 | 2.53 Mn |
| Sep 30, 2020 | 2.53 Mn |
| Jun 30, 2020 | 2.53 Mn |
| Jun 30, 2020 | 2.53 Mn |
| Mar 31, 2020 | 2.53 Mn |
| Mar 31, 2020 | 2.53 Mn |
| Dec 31, 2019 | 2.53 Mn |
| Dec 31, 2019 | 2.53 Mn |
| Sep 30, 2019 | 3.25 Mn |
| Sep 30, 2019 | 3.25 Mn |
| Jun 30, 2019 | 3.25 Mn |
| Jun 30, 2019 | 3.25 Mn |